Estimation of radiation doses and lifetime attributable risk of radiation-induced cancer in the uterus and prostate from abdomen pelvis CT examinations

被引:8
作者
Shubayr, Nasser [1 ]
Alashban, Yazeed [2 ]
机构
[1] Jazan Univ, Coll Appl Med Sci, Dept Diagnost Radiog Technol, Jazan, Saudi Arabia
[2] King Saud Univ, Coll Appl Med Sci, Radiol Sci Dept, Riyadh, Saudi Arabia
关键词
ionizing radiation; cancer incidence; cancer mortality; lifetime attributable risk; computed tomography; uterus; prostate; ATOMIC-BOMB SURVIVORS; COMPUTED-TOMOGRAPHY; MORTALITY; REDUCTION; EMPLOYEES; EXPOSURE; RATES;
D O I
10.3389/fpubh.2022.1094328
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Computed tomography (CT) scans are one of the most common radiation imaging modalities, and CT scans are rising steadily worldwide. CT has the potential to enhance radiography practice, but it also has the risk of drastically increasing patient doses. One CT procedure for the abdomen pelvis (AP) area can expose a patient's prostate or uterus to a substantial radiation dose, leading to concerns about radiation-induced cancer. This study aimed to estimate organ doses of the uterus and prostate and evaluate the lifetime attributable risk (LAR) of cancer incidence and mortality resulting from AP CT examinations. This retrospective study included 665 patients, of which 380 (57%) were female, and 285 (43%) were male. Data were collected from the picture archiving and communication system for AP CT procedures and exposure parameter data. Organ doses for the uterus and prostate were calculated using National Cancer Institute CT (NCICT) software. Based on the risk models proposed by the BEIR VII report, the calculated organ doses were used to estimate the LAR of prostate and uterus cancer incidence and mortality due to radiation exposure from AP CT procedures. The mean effective dose resulting from AP CT for females and males was 5.76 +/- 3.22 (range: 1.13-12.71 mSv) and 4.37 +/- 1.66 mSv (range: 1.36-8.07 mSv), respectively. The mean organ dose to the uterus was 10.86 +/- 6.09 mGy (range: 2.13-24.06 mGy). The mean organ dose to the prostate was 7.00 +/- 2.66 mGy (range: 2.18-12.94 mGy). The LAR of uterus and prostate cancer incidence was 1.75 +/- 1.19 cases and 2.24 +/- 1.06 cases per 100,000 persons, respectively. The LAR of cancer mortality rates from uterus and prostate cancers were 0.36 +/- 0.22 and 0.48 +/- 0.18 cases per 100,000 persons, respectively. The LAR of prostate and uterus cancer occurrence and mortality from radiation doses with AP CT procedures was low but not trivial. Therefore, efforts should be made to lower patient doses while retaining image quality. Although the minimization of the patient's radiation dose must guide clinical practice, the estimated slight increase in risk could aid in easing fears regarding well-justified AP CT procedures.
引用
收藏
页数:7
相关论文
共 50 条
[31]   Radiation Organ Dose Measurement and Cancer Risk Estimation in CT Examination on Trauma Patients [J].
Vafaei, Ali ;
Khosravi, Nafiseh ;
Barjouei, Nazli Shojaei ;
Sendani, Neda Gholizadeh ;
Sadeghi, Ali Oloumi ;
Akhtari, Amin Shams .
MIDDLE EAST JOURNAL OF CANCER, 2019, 10 (03) :206-213
[32]   Radiation Risk From CT: Implications for Cancer Screening [J].
Albert, Jeffrey M. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 201 (01) :W81-W87
[33]   Estimation of radiation cancer risk in CT-KUB [J].
Karim, M. K. A. ;
Hashim, S. ;
Bakar, K. A. ;
Bradley, D. A. ;
Ang, W. C. ;
Bahrudin, N. A. ;
Mhareb, M. H. A. .
RADIATION PHYSICS AND CHEMISTRY, 2017, 137 :130-134
[34]   Physicians' and Midlevel Providers' Awareness of Lifetime Radiation-Attributable Cancer Risk Associated With Commonly Performed CT Studies: Relationship to Practice Behavior [J].
Puri, Savita ;
Hu, Rui ;
Quazi, Robin R. ;
Voci, Susan ;
Veazie, Peter ;
Block, Robert .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (06) :1328-1336
[35]   Patient radiation doses from adult CT examinations at the Souss Massa Regional Hospital [J].
EL Fahssi, M. ;
Semghouli, S. ;
Amaoui, B. ;
Jroundi, L. ;
Caoui, M. .
RADIOPROTECTION, 2024, 59 (01) :13-18
[36]   Estimated risk of radiation-induced cancer from paediatric chest CT: two-year cohort study [J].
Tilo Niemann ;
Lucie Colas ;
Hans W. Roser ;
Teresa Santangelo ;
Jean Baptiste Faivre ;
Jaques Remy ;
Martine Remy-Jardin ;
Jens Bremerich .
Pediatric Radiology, 2015, 45 :329-336
[37]   Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients [J].
Tamura, Masaya ;
Sakurai, Hideyuki ;
Mizumoto, Masashi ;
Kamizawa, Satoshi ;
Murayama, Shigeyuki ;
Yamashita, Haruo ;
Takao, Seishin ;
Suzuki, Ryusuke ;
Shirato, Hiroki ;
Ito, Yoichi M. .
JOURNAL OF RADIATION RESEARCH, 2017, 58 (03) :363-371
[38]   Risk of Radiation-induced Breast Cancer from Mammographic Screening [J].
Yaffe, Martin J. ;
Mainprize, James G. .
RADIOLOGY, 2011, 258 (01) :98-105
[39]   Variability Between Radiation-Induced Cancer Risk Models in Estimating Oncogenic Risk in Intensive Care Unit Patients [J].
Quaia, Emilio ;
Zanon, Chiara ;
Torchio, Riccardo ;
Dughiero, Fabrizio ;
De Monte, Francesca ;
Paiusco, Marta .
TOMOGRAPHY, 2025, 11 (04)
[40]   Radiation-induced lymphopenia in proton therapy for prostate cancer [J].
Al-Hamami, Sarah F. A. ;
Kurucz, Samuel ;
Vondracek, Vladimir ;
Pekar, Vladimir ;
Kubes, Jiri .
RADIOTHERAPY AND ONCOLOGY, 2024, 194 :S5160-S5162